Header Logo

Connection

Jacob Rotmensch to Quinazolines

Back to Details
This is a "connection" page, showing publications Jacob Rotmensch has written about Quinazolines.
Jacob Rotmensch
Connection Strength
0.121
Quinazolines
  1. A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Sep; 138(3):507-12.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.